Germany's GPC Biotech announced on Thursday that it is shuttering its operations in Waltham, MA and laying off 16 percent of its workers as it consolidates its drug discovery programs in Munich. The decision follows the termination of a collaboration with Altana in Waltham. GPC bought Axxima Pharmaceuticals in 2005 and hired its research scientists.
- for more, check out this release on the closing
- here's the report from The Boston Globe